Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Veteran MedTech leader and hospital group CEO joins CMR Surgical as global Chief Commercial Officer
-
Glycotope and Evotec enter licensing agreement to combine Glycotope antibodies and Evotec’s immune cell engager platform
-
Ryvu Therapeutics Presents Data on RVU120 at the 2023 American Society of Hematology (ASH) Annual Meeting
-
Azerion simplifies loan structures between Azerion and Principion
-
Groupe Casino: Disposal of Casino stake in Éxito Group
-
Nyxoah Announces Real World Case Series Demonstrating Positive Results in Treating CCC Patients with Genio®
-
Groupe Casino: Communication by the Casino group
-
Outcome of Inbank Subordinated Bond Subscription
-
-
Basilea announces that FDA approves expanded use of antifungal Cresemba® (isavuconazole) in the United States in children with invasive aspergillosis and invasive mucormycosis
-
BGHL (GBP): NAV(s)
-
BGHL (EUR): NAV(s)
-
Novartis investigational iptacopan Phase III study demonstrates clinically meaningful and statistically significant proteinuria reduction in patients with C3 glomerulopathy (C3G)
-
New data for Roche’s Columvi and Lunsumio presented at ASH 2023 support continued benefit for people with lymphoma
-
Start of Day Message
-
Nokia and BT Group sign agreement to drive new 5G monetization opportunities through telco APIs
-
Coop Pank AS results for November 2023
-
Azafaros’ Phase 2 RAINBOW study, evaluating nizubaglustat in GM2 and NPC patients, is now fully enrolled
-
Flash News: OKX Wallet Now Integrated with Raydium
-
Hepsor JG SIA, Hepsor AS group company, signed 4 million euro loan agreement for financing the construction of Annenhof Majas project
-
Proposal for Adoption of Resolutions of Shareholders´ General Meeting of AS PRFoods Without Convening a Meeting
-
Porgera Gold Mine Set to Restart Production This Month
-
Kymera Therapeutics Presents Interim Results from STAT3 Degrader Phase 1 Clinical Trial at American Society of Hematology Annual Meeting
-
BLUE RIDGE BANKSHARES ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Blue Ridge Bankshares, Inc. and Encourages Investors to Contact the Firm
-
EHANG ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against EHang Holdings Limited and Encourages Investors to Contact the Firm
-
NATIONAL INSTRUMENTS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against National Instruments Corporation and Encourages Investors to Contact the Fi
-
EXPENSIFY ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Expensify, Inc. and Encourages Investors to Contact the Firm
-
ROBLOX ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Roblox Corporation and Encourages Investors to Contact the Firm
-
LIVEPERSON ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against LivePerson, Inc. and Encourages Investors to Contact the Firm
-
CHARGEPOINT ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against ChargePoint Holdings Inc. and Encourages Investors to Contact the Firm
-
SOLAREDGE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against SolarEdge Technologies, Inc. and Encourages Investors to Contact the Firm
-
LI-CYCLE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Li-Cycle, Corp. and Encourages Investors to Contact the Firm
-
BARCLAYS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Barclays PLC and Encourages Investors to Contact the Firm
-
ROCKLEY ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Rockley Photonics Holdings Limited and Encourages Investors to Contact the Firm
-
ACELYRIN ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Acelyrin, Inc. and Encourages Investors to Contact the Firm
-
PAYCOM ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Paycom Software, Inc. and Encourages Investors to Contact the Firm
-
ILLUMINA ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Illumina, Inc. and Encourages Investors to Contact the Firm
-
JAMES RIVER ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against James River Group Holdings, Ltd. and Encourages Investors to Contact the Firm
-
FMC ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against FMC Corporation and Encourages Investors to Contact the Firm
-
SCYNEXIS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against SCYNEXIS, Inc. and Encourages Investors to Contact the Firm
-
ADAPTHEALTH ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against AdaptHealth Corp. and Encourages Investors to Contact the Firm
-
BRAINSTORM CELL ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Brainstorm Cell Therapeutics Inc. and Encourages Investors to Contact the Firm
-
DOCGO ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against DocGo, Inc. and Encourages Investors to Contact the Firm
-
FARFETCH ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Farfetch Limited and Encourages Investors to Contact the Firm
-
ORTHOFIX ALERT: Bragar Eagel & Squire, P.C. is Investigating Orthofix Medical Inc. on Behalf of Orthofix Stockholders and Encourages Investors to Contact the Firm
-
DERMTECH ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against DermTech, Inc. and Encourages Investors to Contact the Firm
-
APPLIED MATERIALS ALERT: Bragar Eagel & Squire, P.C. is Investigating Applied Materials, Inc. on Behalf of Applied Materials Stockholders and Encourages Investors to Contact the Firm
-
INSPIRED ENTERTAINMENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Inspired Entertainment, Inc. on Behalf of Inspired Entertainment Stockholders and Encourages Investors to Contact the Firm
-
EAGLE PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. is Investigating Eagle Pharmaceuticals, Inc. on Behalf of Eagle Pharmaceuticals Stockholders and Encourages Investors to Contact the Firm
-
NovalGen presents NVG-111 clinical data in hematological malignancies in an oral session and preclinical data for next-generation AR T cell engager NVG-222 at the 65th American Society of Hematology A


